Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: Short-term results

Retina

Volumn 31, Issue 4, 2011, Pages 772-778

  Fujita, Kyoko ^a   Yuzawa, Mitsuko ^a   Mori, Ryusaburou ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VERTEPORFIN;

ADULT; AGED; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MICROPERIMETRY; PERIMETRY; PHOTODYNAMIC THERAPY; PROSPECTIVE STUDY; RETINA DETACHMENT; RETINAL SENSITIVITY; TREATMENT OUTCOME; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; CENTRAL SEROUS CHORIORETINOPATHY; CHRONIC DISEASE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 79955073529     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181f049d3     Document Type: Article

References (17)

1. Gass JD. Pathogenesis of disciform detachment of neuroepithelium. J Ophthalmol 1967;63:1-139.
2. Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 1989;96:854-859. (Pubitemid 19165113)
3. Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term followup of central serous chorioretinopathy. Br J Ophthalmol 1984; 68:815-820. (Pubitemid 15146084)
4. Wang MS, Sander B, Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 2002;133: 787-793. (Pubitemid 34580626)
5. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003;87:1453-1458. (Pubitemid 38010546)
6. Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003;23:752-763. (Pubitemid 38040573)
7. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy. One-year results of a randomized controlled trial. Ophthalmology 2008;115:1756-1765.
8. Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003;23:288-298. (Pubitemid 36792972)
9. Taban M, Boyer DS, Thomas EL, Taban M. Chronic central serous chorioretinopathy: Photodynamic therapy. Am J Ophthalmol 2004;137:1073-1080. (Pubitemid 38759356)
10. Ober MD, Yannuzzi LA, Do DV, et al. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 2005;112:2088-2094. (Pubitemid 41720985)
11. Moon JW, Yu HG, Kim TW, Kim HC, Chung H. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2009; 247:1315-1323.
12. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112: 1057-1062. (Pubitemid 24272611)
13. Zacks DN, Ezra E, Terada Y, et al. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. Invest Ophthalmol Vis Sci 2002;43:2384-2391. (Pubitemid 34700672)
14. Husain D, Kramer M, Kenny AG, et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci 1999;40: 2322-2331. (Pubitemid 29418388)
15. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials. TAP report 1. Arch Ophthalmol 1999;117:1329-1345.
16. Piccolino FC, de la Longrais RR, Ravera G, et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 2005;139:87-99. (Pubitemid 40094844)
17. Reibaldi M, Cardascia N, Longo A, et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 2009;149:307-315.